EP
GHDX

Eversept Partners’s Genomic Health, Inc. GHDX Stock Holding History

Eversept Partners’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-38,403
Closed -$2.23M – 74
2019
Q2 		$2.23M Buy
+38,403
New +$2.27M 0.63% 33
2019
Q1 		– Sell
-23,866
Closed -$1.54M – 70
2018
Q4 		$1.54M Buy
+23,866
New +$1.67M 0.83% 23

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Eversept Partners's GHDX Position: Q3 2019 in Review

Eversept Partners sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 38,403 shares — an estimated $2.23M sold.

Eversept Partners first reported a position in GHDX in Q4 2018 and held it in 2 quarters. The position peaked at $2.23M in Q2 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Eversept Partners reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Eversept Partners sold 38,403 Genomic Health, Inc. shares in Q3 2019, an estimated $2.23M.
  • Eversept Partners first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 2 quarters.
  • Eversept Partners's Genomic Health, Inc. position peaked at $2.23M in Q2 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Eversept Partners's 13F filing for Q3 2019, filed 13 Nov 2019.